A recent study, led by Dr. Erika Isolauri, a professor of paediatrics at the University of Turku and chief physician at the Department of Paediatrics at Turku University Hospital in Finland, has found that perinatal probiotic administration is safe and may have the long-term effect of decreasing allergy prevalence.

A recent study led by Dr. Alex Mira (FISABIO, Spain) and Dr. Maria C. Jenmalm (Linköping University, Sweden) and researchers at IATA-CSIC (Spain) has presented an analysis of a total of 192 faecal samples from 28 healthy children and 20 children developing allergic symptoms at age seven, from when the children were 1 and 12 months of age. It has found that children who develop asthma or allergies later in life have altered immune responses to intestinal bacteria in the gut mucosal environment at an early age.

Researchers know the fecal microbiota of infants is a treasure trove of information -- it can reveal details about delivery mode and diet -- but microbiota-based predictions about future health are only beginning to emerge. A team of researchers led